
    <rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
      <channel>
        <title>Articles tagged with Media from Medical Marketing and Media</title>
        <link>http://www.mmm-online.com/media/topic/198/</link>
        <description>Articles tagged with Media from Medical Marketing and Media</description>
        <itunes:author>MMM</itunes:author>
        <itunes:subtitle></itunes:subtitle>
        <itunes:summary></itunes:summary>
        <itunes:owner>
            <itunes:name></itunes:name>
            <itunes:email>mmmsubs@haymarketmedia.com</itunes:email>
        </itunes:owner>
        <itunes:category text="BUSINESS">
            <itunes:category text="BUSINESS NEWS" /> 
        </itunes:category> 
        <itunes:image href='http://media.haymarketmedia.com/images/32/MMM_logo_28402_31022.gif'></itunes:image>
        <itunes:explicit>no</itunes:explicit>
  
        <item>
          <title>Business Briefs: Docs question Gleevec price, Sanofi pill may delay MS onset</title>
          <description>Doctors call out Novartis on drug prices; Aubagio shows strong top-line data in trials; and overseas docs increasingly turn to digital.</description>
          <link>http://www.mmm-online.com/business-briefs-docs-question-gleevec-price-sanofi-pill-may-delay-ms-onset/article/290560/</link>
          <pubDate>Thu, 25 Apr 2013 17:17:27 GMT</pubDate>
          <itunes:summary>Doctors call out Novartis on drug prices; Aubagio shows strong top-line data in trials; and overseas docs increasingly turn to digital.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Rare disease awareness more than just a day for pharmas</title>
          <description>Industry observances of Rare Disease Awareness Day are getting more elaborate of late—perhaps not solely for altruistic reasons, as a third of NMEs approved by FDA over the past five years were for the treatment of rare diseases.</description>
          <link>http://www.mmm-online.com/rare-disease-awareness-more-than-just-a-day-for-pharmas/article/282345/</link>
          <pubDate>Thu, 28 Feb 2013 17:28:50 GMT</pubDate>
          <itunes:summary>Industry observances of Rare Disease Awareness Day are getting more elaborate of late—perhaps not solely for altruistic reasons, as a third of NMEs approved by FDA over the past five years were for the treatment of rare diseases.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Business briefs: Allergan, Amgen, Wiley</title>
          <description>Allergan&apos;s 2013 outlook scores points with at least one analyst, Amgen is laying off 160 staff, and Wiley renews a publishing relationship.</description>
          <link>http://www.mmm-online.com/business-briefs-allergan-amgen-wiley/article/279080/</link>
          <pubDate>Tue, 05 Feb 2013 17:22:35 GMT</pubDate>
          <itunes:summary>Allergan&apos;s 2013 outlook scores points with at least one analyst, Amgen is laying off 160 staff, and Wiley renews a publishing relationship.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Company news: Edelman, Pfizer, Publicis, Lippincott</title>
          <description>Healthcare PR giant Dan Edelman dies; Pfizer says &apos;no comment&apos; on breakup speculation; Publicis Healthcare snags a new SVP; Lippincott gives nurses a new drug diagnosis tool.</description>
          <link>http://www.mmm-online.com/company-news-edelman-pfizer-publicis-lippincott/article/276089/</link>
          <pubDate>Tue, 15 Jan 2013 17:15:17 GMT</pubDate>
          <itunes:summary>Healthcare PR giant Dan Edelman dies; Pfizer says &apos;no comment&apos; on breakup speculation; Publicis Healthcare snags a new SVP; Lippincott gives nurses a new drug diagnosis tool.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Publicis aims to up its healthcare media game</title>
          <description>Publicis Healthcare Communications Group is retooling its media offering, placing media talent at each of its shops and creating a centralized media hub for execution.</description>
          <link>http://www.mmm-online.com/publicis-aims-to-up-its-healthcare-media-game/article/275130/</link>
          <pubDate>Mon, 07 Jan 2013 18:36:32 GMT</pubDate>
          <itunes:summary>Publicis Healthcare Communications Group is retooling its media offering, placing media talent at each of its shops and creating a centralized media hub for execution.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Growth in devices, online video to drive media this year, buyers say</title>
          <description>What changes in marketing or audience viewing habits might impact pharma&apos;s media investment this year? Media buyers weigh in on the hot channel trends.</description>
          <link>http://www.mmm-online.com/growth-in-devices-online-video-to-drive-media-this-year-buyers-say/article/274880/</link>
          <pubDate>Fri, 04 Jan 2013 17:25:20 GMT</pubDate>
          <itunes:summary>What changes in marketing or audience viewing habits might impact pharma&apos;s media investment this year? Media buyers weigh in on the hot channel trends.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Company news: Capgemini, HealthPrize and Warc International</title>
          <description>The amount of revenue pharma leaves on the table due to non-adherence is much more than previously thought, a new study suggests.</description>
          <link>http://www.mmm-online.com/company-news-capgemini-healthprize-and-warc-international/article/269823/</link>
          <pubDate>Mon, 26 Nov 2012 20:24:21 GMT</pubDate>
          <itunes:summary>The amount of revenue pharma leaves on the table due to non-adherence is much more than previously thought, a new study suggests.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Print: Still not dead</title>
          <description>Studies show that printed pieces still hold sway in the industry.</description>
          <link>http://www.mmm-online.com/print-still-not-dead/article/269366/</link>
          <pubDate>Wed, 21 Nov 2012 15:27:57 GMT</pubDate>
          <itunes:summary>Studies show that printed pieces still hold sway in the industry.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Pfizer, J&amp;J creative reviews &apos;meh&apos; on the medical side</title>
          <description>For the big mainline ad agencies, the recent creative consolidations at Pfizer and Johnson &amp; Johnson are a big deal, but to their medical agency subsidiaries, they mostly represent a codification of where things stood to begin with.</description>
          <link>http://www.mmm-online.com/pfizer-jj-creative-reviews-meh-on-the-medical-side/article/265644/</link>
          <pubDate>Fri, 26 Oct 2012 20:10:41 GMT</pubDate>
          <itunes:summary>For the big mainline ad agencies, the recent creative consolidations at Pfizer and Johnson &amp; Johnson are a big deal, but to their medical agency subsidiaries, they mostly represent a codification of where things stood to begin with.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Pharma finds happy medium in 90-sec. TV spot</title>
          <description>The advent of new ad-unit lengths is bringing drugmakers much-needed relief from the high cost of advertising on television.</description>
          <link>http://www.mmm-online.com/pharma-finds-happy-medium-in-90-sec-tv-spot/article/261219/</link>
          <pubDate>Fri, 28 Sep 2012 13:37:31 GMT</pubDate>
          <itunes:summary>The advent of new ad-unit lengths is bringing drugmakers much-needed relief from the high cost of advertising on television.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
      </channel>
    </rss>  
  